致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Human SIRP Beta 1 isoform 3, Avi-His-tag
目录号 NBL-242065
别名 SIRP Beta 1 isoform 3; SIRP-beta-1 isoform 3; SIRPB1; CD172b; DKFZp686A05192; FLJ26614; 9930027N05Rik; SIRP-beta; Sirpb; Sirpb1; Sirpb1a
外观 see COA
分子量 Glu30-Leu371
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 Q5TFQ8-1
备注2
目录号 规格 价格 库存状态  
NBL-242065-100ug 100ug Inquire Inquire
NBL-242065-1mg 1mg Inquire Inquire
NBL-242065-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Human SIRP Beta 1 isoform 3, Avi-His-tag


Catalog#:

NBL-242065


Description:

NebuSelect™ Recombinant Human SIRP Beta 1 isoform 3, Avi-His-tag(Cat#NBL-242065) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Glu30-Leu371.


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 39.9 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.


Target Name:

SIRP Beta 1 isoform 3; SIRP-beta-1 isoform 3; SIRPB1; CD172b; DKFZp686A05192; FLJ26614; 9930027N05Rik; SIRP-beta; Sirpb; Sirpb1; Sirpb1a


Target Information:

Signal regulatory protein β1 (SIRPB1) is a signal regulatory protein member of the immunoglobulin superfamily and is capable of modulating receptor tyrosine kinase-coupled signaling. Copy number variations at the SIRPB1 locus were previously reported to associate with prostate cancer aggressiveness in patients.SIRPB1 gene amplification and overexpression were detected in prostate cancer specimens. The knockdown of SIRPB1 significantly suppressed cell growth in colony formation assays and cell mobility.


Amino Acid Sequence: 

Glu30-Leu371


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品

可以介绍下你们的产品么

你们是怎么收费的呢

现在有优惠活动吗

请您留言

欢迎来到辰辉创聚生物,客服电话15801534258(微信同号),或发邮件至info@nebulabio.cn,在线客服QQ 2369446524

提交